The Casey Eye Institute is dedicated to meeting all your eye care needs. With convenient locations in Portland, Longview, Vancouver, Astoria and Hood River, Casey doctors provide you the latest state-of-the-art eye care. Browse our services
Casey's commitment to eye care
At OHSU Casey Eye Institute, every member of our team is dedicated to a single mission: to promote the best possible eye health for you through education, research, clinical leadership and service to the community.
Casey is a world-recognized academic regional eye center that attracts top specialists from around the globe. We are known for developing and utilizing the very latest treatments and technologies.
Building on decades of innovation and collaboration, OHSU Casey Eye Institute is embracing a bold new goal – to eliminate blindness in Oregon and beyond. To set the stage for a new era of innovation, the institute is building a new facility to accelerate discovery and help reach more patients with better options, sooner.
The building will be adjacent to the current structure on Marquam Hill, and be named the Oregon Elks Children's Eye Clinic, in recognition of a significant gift from the Elks Youth Eye Service (EYES) foundation.
The building will house the Elks Children's Eye Clinic, the Macular Degeneration Center and the Ophthalmic Genetics Center, and have space for additional research and patient care needs.
Groundbreaking on the new facility is in June 2018.
OHSU Casey Eye Institute to provide new, FDA-approved gene therapy for a form of blindness
Visit by Buddhist high monk celebrates partnership between Casey Eye Institute and Myanmar eye hospital
OHSU kicked off its global health collaboration in Myanmar with a special visit in July by the Buddhist High Monk of Myanmar. The event, which took place at Casey Eye Institute, featured a symbolic signing of a memorandum of understanding –or MOU –to honor the growing relationship between OHSU and the Tipitaka Eye Hospital in Myanmar.
Study finds that gene therapy for rare eye disease helps kids most
Scientists at OHSU Casey Eye Institute and Baylor College of Medicine's Cullen Eye Institute recently published findings from a clinical trial in the journal Ophthalmology, which showed that children had the greatest benefit from gene therapy for treatment of Leber congenital amaurosis (LCA), a rare genetic disorder that causes childhood blindness